Baseline platelet counts and derived inflammatory biomarkers: prognostic relevance in metastatic melanoma patients receiving Endostar plus dacarbazine and cisplatin

Background: The clinical efficacy and safety of Endostar combined with chemotherapy in the treatment of metastatic malignant melanoma (MM) were analyzed and the indicators capable of predicting the efficacy of the regimen were identified to guide clinical practice. Patients and methods: The clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lingge, Xu, Yu, Luo, Peng, Chen, Shiqi, Zhu, Huiyan, Wang, Chunmeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500443/
https://www.ncbi.nlm.nih.gov/pubmed/31118790
http://dx.doi.org/10.2147/CMAR.S194176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500443/
https://www.ncbi.nlm.nih.gov/pubmed/31118790
http://dx.doi.org/10.2147/CMAR.S194176

Ejemplares similares